Modeling drug detection and diagnosis with the 'drug evaluation and classification program'

Edna Schechtman, David Shinar

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

In this study, we propose formal models and algorithms to detect drug impairment and identify the impairing drug type, on the basis of data obtained by a Drug Evaluation and Classification (DEC) investigation. The DEC program relies on measurements of vital signs and observable signs and symptoms. A formal model, based on data collected by police officers trained to detect and identify drug impairments, yielded sensitivity levels greater than 60% and specificity levels greater than 90% for impairments caused by cannabis, alprazolam, and amphetamine. For codeine, with a specificity of nearly 90% the sensitivity was only 20%. Using logistic regression, the formal model was much more accurate than the trained officers in identifying impairments from cannabis, alprazolam, and amphetamine. Both the formal model and the officers were quite poor in identifying codeine impairment. In conclusion, the joint application of the DECP procedures with the formal model is useful for drug detection and identification.

Original languageEnglish
Pages (from-to)852-861
Number of pages10
JournalAccident Analysis and Prevention
Volume37
Issue number5
DOIs
StatePublished - 1 Sep 2005

Keywords

  • Drug evaluation and classification program
  • Drug impairment
  • Drugs and driving

ASJC Scopus subject areas

  • Human Factors and Ergonomics
  • Safety, Risk, Reliability and Quality
  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Modeling drug detection and diagnosis with the 'drug evaluation and classification program''. Together they form a unique fingerprint.

Cite this